Navigation Links
Ceragenix Announces Results from Phase IV Study of EpiCeram Meet,All Primary and Secondary Endpoints

DENVER--(BUSINESS WIRE)--Apr 24, 2007 - Ceragenix Pharmaceuticals Inc. (OTCBB:CGXP) today announced positive results from its post-clearance marketing study comparing EpiCeram's(TM) efficacy to that of Cutivate(R) cream, a mid-strength topical steroid in the treatment of moderate-to-severe atopic dermatitis (AD).

The study, which took place at five centers, consisted of 113 pediatric patients, with 59 patients receiving treatment with Cutivate(R) and 54 patients receiving treatment with EpiCeram(TM). After 28 days of treatment, the study demonstrated that: -0-

       Both EpiCeram(TM) and Cutivate(R) produced significant

       improvement in patients' conditions after 28 days of treatment;


       There were no statistically significant differences between the

       groups treated with EpiCeram(TM) compared to those treated with

       Cutivate(R) as measured by the SCORAD index at Day 28 (the

       primary outcome measure) or in the percentage of patients

       assessed to be "clear or almost clear" by physician assessment

       at Day 28 (a secondary outcome measure).


       Both EpiCeram(TM) and Cutivate(R) produced significant relief

       from itching (pruritus) and improvement in sleep habits after

       28 days of treatment and that there was no statistically

       significant difference between the two treatments in these

       measures at this time point (both secondary outcome measures).

"The data from this study demonstrate that EpiCeram(TM) is effective and offers both the clinician and parents a new approach for treating atopic dermatitis without the risks often associated with long-term use of topical steroids or immunosuppressants," said Lawrence Charles Parish, M.D., Clinical Professor of Dermatology and Cutaneous Biology at Jefferson Medical College of Thomas Jefferson University in Philadelphia, one of the study's principal investigators.

Atopi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
2. Ceragenix Announces New Publication of Scientific Research on Ceragenin Technology
3. Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm Formation in 21 Day Study
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:1/14/2014)...   NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
(Date:1/14/2014)... , Jan. 14, 2014   Evidera , a ... announced that the Center for Drug Evaluation and Research ... first draft qualification guidance document for a patient-reported outcome ... of Chronic Pulmonary Disease Tool [EXACT] for Measurement of ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... that a new market research report is available ... markets and companies http://www.reportlinker.com/p0203545/Nanobiotechnologies--applications-markets-and-companies.html ... creation and utilization of materials, devices, and systems ... scale (a nanometer is one billionth of a ...
... This Week , a leading industry publication, has honored Amedica®/US ... for Spine Care in 2010 . Amedica/US Spine, ... unique silicon nitride (SiN) ceramic technologies, received recognition in the ... Valeo® AL Lumbar Spacer and Best New Technology in ...
Cached Medicine Technology:Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 3Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 4Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 5Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 6Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 7Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 8Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 9Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 10Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 11Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 12Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 13Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 14Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 15Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 16Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 17Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 18Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 19Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 20Reportlinker Adds Nanobiotechnologies - Applications, Markets and Companies 21Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week 2
(Date:4/24/2014)... by a scientist at the University of York reveals ... the development of the nervous system may also play ... A research team, led by Dr Will Brackenbury, ... Biology at York, has studied how voltage-gated sodium channels ... are found in the membranes of excitable cells, such ...
(Date:4/23/2014)... healthy, unrelated donors was safe and effective in ... Clostridium difficile , according to a new ... and available online. Known as fecal microbiota ... via a colonoscope or a nasogastric tube. The ... treatment more readily available to patients. , A ...
(Date:4/23/2014)... say clinical trials for a new experimental drug ... promising. Patients treated with CPX-351, a combination of ... better responses than patients treated with the standard ... leukemia is an aggressive blood cancer with very ... patients," explained Jeffrey Lancet, M.D., senior member of ...
(Date:4/23/2014)... scientific director at the National Institute of Arthritis and ... 2014 recipient of the Ross Prize in Molecular Medicine, ... Molecular Medicine . The award will be given on ... in Manhattan, followed by scientific presentations by Dr. O,Shea ... National Institutes of Health. , The award, which includes ...
(Date:4/23/2014)... Va., April 23, 2014 The American Society for ... "The Role of Postoperative Radiation Therapy for Endometrial ... use of adjuvant radiation therapy in the treatment ... published in the May-June 2014 issue of ... practice journal of ASTRO. The full-length guideline is ...
Breaking Medicine News(10 mins):Health News:Breast cancer replicates brain development process 2Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3
... VIEW, Calif., June 24 MAP,Pharmaceuticals, Inc. ... Telesso,Technologies Limited, formerly Eiffel Technologies Limited ("Eiffel"), ... Pharmaceuticals previously licensed,intellectual property and know-how, as ... to its supercritical fluid technology ("SCF")., ...
... CEO of America,s Health Insurance Plans (AHIP), today ... House of Representatives,passage of H.R. 6331:, "Congress ... beneficiaries to pay for the increase in physician ... on vulnerable seniors.,As seniors learn the details of ...
... inroads, CDC says , , TUESDAY, June 24 (HealthDay ... an increase of more than 3 million over two years, ... , In addition, another 57 million Americans had pre-diabetes, which ... some good news. Over two years, the proportion of people ...
... Assistant Professor Adela Ben-Yakar at The University of Texas ... a single cell while leaving nearby cells intact, which ... and other diseases. , "You can remove a cell ... above and below it," Ben-Yakar says. "And you can ...
... both military and civilian, is on the ... rise,Proposed change to Auto No ... ... The number of Michigan,residents living with traumatic brain injury (TBI) is growing, according to,the second ...
... awareness of how to play safely in,the summer sun, ... hours, and a host of outdoor activities to enjoy,everyday, ... of more,time under the sun. With the official start ... against overexposure to the,sun, which can lead to heat-related ...
Cached Medicine News:Health News:MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited 2Health News:MAP Pharmaceuticals Acquires Proprietary Drug Particle Formulation Technology From Eiffel/Telesso Technologies Limited 3Health News:AHIP Statement on House Passage of H.R. 6331 2Health News:24 Million Americans Had Diabetes in 2007 2Health News:Laser surgery probe targets individual cancer cells 2Health News:Brain Injury Association of Michigan Outlines the Current State of Brain Injury 2Health News:Brain Injury Association of Michigan Outlines the Current State of Brain Injury 3Health News:Brain Injury Association of Michigan Outlines the Current State of Brain Injury 4Health News:Brain Injury Association of Michigan Outlines the Current State of Brain Injury 5Health News:Physicians at Northwestern Memorial Offer Sun Safety Tips Just in Time for the Start of Summer 2Health News:Physicians at Northwestern Memorial Offer Sun Safety Tips Just in Time for the Start of Summer 3Health News:Physicians at Northwestern Memorial Offer Sun Safety Tips Just in Time for the Start of Summer 4
... for excising soft tissue more efficiently than a ... serrated edge on the straight scissor helps to ... the jaws for more efficient resection.,The curved scissors, ... the perfect tools for ACL stump removal, meniscectomies ...
... Scissor is ideal for excising soft tissue more ... the joint. The serrated edge on the straight ... hold tissue within the jaws for more efficient ... jaw curvatures, are the perfect tools for ACL ...
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
... Series I Instrument program offers state-of-the-art quality ... while maintaining strength and durability. Low profile ... tight joint spaces. Series I instruments are ... style, size and angle required for large ...
Medicine Products: